{"filing":{"accession_number":"0001437749-26-019909","cik":"0001053691","ticker":"CRVO","company_name":"CervoMed Inc.","form":"8-K","filing_date":"2026-06-09","report_date":null,"primary_document":"crvo20260609_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926019909/crvo20260609_8k.htm"},"events":[{"id":5989,"run_id":5257,"accession_number":"0001437749-26-019909","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of CervoMed's 2026 Annual Meeting of Stockholders held on June 8, 2026. The filing presents voting results for four proposals: election of eight directors, ratification of RSM US LLP as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2025 Equity Incentive Plan. All proposals passed with the requisite majorities. This is a material disclosure as it documents shareholder approval of governance and compensation matters.","company_name":"CervoMed Inc.","ticker":"CRVO","filing_date":"2026-06-09","form":"8-K","submitted_at":null,"items":[{"id":5378,"accession_number":"0001437749-26-019909","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of CervoMed's 2026 Annual Meeting of Stockholders held on June 8, 2026. The filing presents voting results for four proposals: election of eight directors, ratification of RSM US LLP as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2025 Equity Incentive Plan. All proposals passed with the requisite majorities. This is a material disclosure as it documents shareholder approval of governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T10:07:13.418700+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5378,"accession_number":"0001437749-26-019909","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of CervoMed's 2026 Annual Meeting of Stockholders held on June 8, 2026. The filing presents voting results for four proposals: election of eight directors, ratification of RSM US LLP as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2025 Equity Incentive Plan. All proposals passed with the requisite majorities. This is a material disclosure as it documents shareholder approval of governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T10:07:13.418700+00:00","company_name":"CervoMed Inc.","ticker":"CRVO","filing_date":"2026-06-09"}]}